C07C 39/245
Monocyclic polyhydroxylic containing halogens bound to ring carbon atoms
Official title: {monocyclic polyhydroxylic containing halogens bound to ring carbon atoms}
C07C39/245 (Monocyclic polyhydroxylic containing halogens bound to ring carbon atoms) appears on 27 US grants and 29 published applications in this corpus.
Search patents in C07C- Granted patents
- 27
- Published applications
- 29
- Assignees
- 29
- Inventors
- 79
- Latest grant
- 14 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 2 |
| 2016 | 3 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 3 | 1 |
| 2021 | 1 | 5 |
| 2022 | 0 | 3 |
| 2023 | 2 | 1 |
| 2024 | 1 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cannabinoid derivatives14 Jan 2025US 12,195,429 B2Canopy Growth Corporation
- Aminated lignin-derived compounds and uses thereof6 Feb 2024US 11,891,349 B2CMBlu Energy AG
- Redox flow battery electrolytes28 Nov 2023US 11,831,017 B2CMBlu Energy AG
- Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex31 Jan 2023US 11,565,996 B2AlternOx Scientific Limited
- Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers1 Jun 2021US 11,021,424 B2PTC Therapeutics, Inc.
- Non-fluorinated resorcinol and hydroquinone analogs as curing agents for fluoroelastomers9 Apr 2026US 2026/0098005 A1The Chemours Company Fc, LLC
- Seaweed extracts, isolated compounds, and methods of treatment11 Jul 2024US 2024/0226211 A9University of Florida Research Foundation, Inc.
- Seaweed extracts, isolated compounds, and methods of treatment25 Apr 2024US 2024/0131097 A1University of Florida Research Foundation, Inc.
- Processes for the preparation of halogenated dihydroxybenzene compounds15 Jun 2023US 2023/0183157 A1Purisys LLC
- Cannabinoid derivatives13 Oct 2022US 2022/0324806 A1Canopy Growth Corporation
Most cited
By later US patents
- Alkylated resorcinol derivatives for the treatment of immune diseases28US 6,274,635 B1Immugen Pharmaceuticals, Inc. · 2001
- Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers19US 9,278,085 B2Edison Pharmaceuticals, Inc. · 2016
- Resorcinolic compounds12US 6,566,560 B2Immugen Pharmaceuticals, Inc. · 2003
- Cannabinol derivatives10US 7,105,685 B22006
- Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers7US 9,447,006 B2Edison Pharmaceuticals, Inc. · 2016